Development and benchmarking of a Deep Learning-based MRI-guided gross tumor segmentation algorithm for Radiomics analyses in extremity soft tissue sarcomas

Jan C. Peeken, Lucas Etzel, Tim Tomov, Stefan Münch, Lars Schüttrumpf, Julius H. Shaktour, Johannes Kiechle, Carolin Knebel, Stephanie K. Schaub, Nina A. Mayr, Henry C. Woodruff, Philippe Lambin, Alexandra S. Gersing, Denise Bernhardt, Matthew J. Nyflot, Bjoern Menze, Stephanie E. Combs, Fernando Navarro

Research output: Contribution to journalArticlepeer-review

1 Scopus citations

Abstract

Background: Volume of interest (VOI) segmentation is a crucial step for Radiomics analyses and radiotherapy (RT) treatment planning. Because it can be time-consuming and subject to inter-observer variability, we developed and tested a Deep Learning-based automatic segmentation (DLBAS) algorithm to reproducibly predict the primary gross tumor as VOI for Radiomics analyses in extremity soft tissue sarcomas (STS). Methods: A DLBAS algorithm was trained on a cohort of 157 patients and externally tested on an independent cohort of 87 patients using contrast-enhanced MRI. Manual tumor delineations by a radiation oncologist served as ground truths (GTs). A benchmark study with 20 cases from the test cohort compared the DLBAS predictions against manual VOI segmentations of two residents (ERs) and clinical delineations of two radiation oncologists (ROs). The ROs rated DLBAS predictions regarding their direct applicability. Results: The DLBAS achieved a median dice similarity coefficient (DSC) of 0.88 against the GTs in the entire test cohort (interquartile range (IQR): 0.11) and a median DSC of 0.89 (IQR 0.07) and 0.82 (IQR 0.10) in comparison to ERs and ROs, respectively. Radiomics feature stability was high with a median intraclass correlation coefficient of 0.97, 0.95 and 0.94 for GTs, ERs, and ROs, respectively. DLBAS predictions were deemed clinically suitable by the two ROs in 35% and 20% of cases, respectively. Conclusion: The results demonstrate that the DLBAS algorithm provides reproducible VOI predictions for radiomics feature extraction. Variability remains regarding direct clinical applicability of predictions for RT treatment planning.

Original languageEnglish
Article number110338
JournalRadiotherapy and Oncology
Volume197
DOIs
StatePublished - Aug 2024

Keywords

  • Deep Learning
  • MRI
  • Radiology
  • Radiomics
  • Radiotherapy
  • Soft tissue sarcoma
  • Tumor Volume

Fingerprint

Dive into the research topics of 'Development and benchmarking of a Deep Learning-based MRI-guided gross tumor segmentation algorithm for Radiomics analyses in extremity soft tissue sarcomas'. Together they form a unique fingerprint.

Cite this